» Articles » PMID: 10457734

Comparison of Euroqol EQ-5D and SF-36 in Patients with Chronic Fatigue Syndrome

Overview
Journal Qual Life Res
Date 1999 Aug 24
PMID 10457734
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

The objective of the study was to compare the Euroqol EQ-5D (Euroqol) and short-form 36 (SF-36) health questionnaires in patients with chronic fatigue syndrome (CFS). One hundred and twenty-seven outpatients referred to a hospital-based infectious disease clinic with a diagnosis of CFS were contacted by post and asked to complete both questionnaires. Additional data were determined from hospital casenotes. Eighty-five patients returned correctly completed questionnaires. Euroqol health values and visual analogue scale (VAS) scores were strongly and significantly correlated with all dimensions of the SF-36, with the exception of physical limitation of role. SF-36 dimensions were in turn strongly and significantly correlated with each other, with the same exception. Patients reported a high degree of physical disability and a moderate degree of emotional or psychological ill-health. The Euroqol elements dealing with mobility and self-care referred to inappropriately severe degrees of disability for these patients with CFS. Similarly some dimensions in the SF-36 were oversensitive and did not discriminate between patients with moderate or severe disability. It was concluded that Euroqol scores correlated strongly with SF-36 scores and provided useful information about patients with CFS and that Euroqol would be a useful tool for the rapid assessment of health status in CFS. The current Euroqol instrument refers to inappropriately severe degrees of disability for patients with CFS and would need to be modified to be maximally useful in this situation.

Citing Articles

Comparison of cognitive behaviour therapy versus activity management, both delivered remotely, to treat paediatric chronic fatigue syndrome/myalgic encephalomyelitis: the UK FITNET-NHS RCT.

Crawley E, Anderson E, Cochrane M, Shirkey B, Parslow R, Hollingworth W Health Technol Assess. 2024; 28(70):1-134.

PMID: 39485730 PMC: 11590115. DOI: 10.3310/VLRW6701.


Advancing Research and Treatment: An Overview of Clinical Trials in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Future Perspectives.

Seton K, Espejo-Oltra J, Gimenez-Orenga K, Haagmans R, Ramadan D, Mehlsen J J Clin Med. 2024; 13(2).

PMID: 38256459 PMC: 10816159. DOI: 10.3390/jcm13020325.


Assessing health state utilities for people with myalgic encephalomyelitis/chronic fatigue syndrome in Australia using the EQ-5D-5L, AQoL-8D and EQ-5D-5L-psychosocial instruments.

Orji N, Cox I, Jason L, Chen G, Zhao T, Rogerson M Qual Life Res. 2023; 33(1):45-57.

PMID: 37561337 PMC: 10784392. DOI: 10.1007/s11136-023-03498-8.


Impact of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) on the quality of life of people with ME/CFS and their partners and family members: an online cross-sectional survey.

Vyas J, Muirhead N, Singh R, Ephgrave R, Finlay A BMJ Open. 2022; 12(5):e058128.

PMID: 35501074 PMC: 9062824. DOI: 10.1136/bmjopen-2021-058128.


Validation of the EQ-5D in Taiwan using item response theory.

Liu T, Ho A, Hsu Y, Hsu C BMC Public Health. 2021; 21(1):2305.

PMID: 34923963 PMC: 8684691. DOI: 10.1186/s12889-021-12334-y.


References
1.
Komaroff A, Fagioli L, Doolittle T, Gandek B, Gleit M, Guerriero R . Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups. Am J Med. 1996; 101(3):281-90. DOI: 10.1016/S0002-9343(96)00174-X. View

2.
Fukuda K, Straus S, Hickie I, Sharpe M, Dobbins J, Komaroff A . The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994; 121(12):953-9. DOI: 10.7326/0003-4819-121-12-199412150-00009. View

3.
Manu P, Affleck G, Tennen H, Morse P, Escobar J . Hypochondriasis influences quality-of-life outcomes in patients with chronic fatigue. Psychother Psychosom. 1996; 65(2):76-81. DOI: 10.1159/000289050. View

4.
Buchwald D, Pearlman T, Umali J, Schmaling K, Katon W . Functional status in patients with chronic fatigue syndrome, other fatiguing illnesses, and healthy individuals. Am J Med. 1996; 101(4):364-70. DOI: 10.1016/S0002-9343(96)00234-3. View

5.
Kind P, Dolan P, Gudex C, Williams A . Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ. 1998; 316(7133):736-41. PMC: 28477. DOI: 10.1136/bmj.316.7133.736. View